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Letters to the Editorincluded in the investigation. For example,
in the study of Fakler and associates,1 new
formulas with new coefficients could be
calculated using 70 patients included in
their investigation and could be validated
against the remaining 73 patients for com-
paring measured and estimated VO2.
Fakler and associates1 reported that the
routine use of assumed VO2 when calcu-
lating cardiac output with the direct Fick
principle might frequently result in large
errors in the estimation of cardiac output
and dependent parameters. To obtain reli-
able cardiac output values by the direct
Fick equation, VO2 should be measured as
concluded by Fakler and associates1 or es-
timated with a new formula calculated us-
ing the population included in the study.
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Reply to the Editor:
We thank Benallal for his comments on our
article and appreciate his remarks.
Our study was specifically designed to
assess the importance of measured oxygen
consumption (VO2) in the preoperative diag-
nostic hemodynamic evaluation during car-
diac catheterization and to assess whether
published formulas allow a reliable calcula-
tion of VO2. We did not intend to develop a
new formula to assume VO2.
Our results emphasize that both the
Krovetz-Goldbloom formula,1 which had
been used to this point in our institution,
and the more commonly used formula pub-
lished by LaFarge and Miettinen2 are not
Tfeasible in all patients to assume VO2 and
thereby calculate cardiac output by the Fick
principle.
Li and colleagues3 presented the impor-
tant conclusion that other predictive equa-
tions published by Lundell and associates,4
Wessel and colleagues,5 and Lindahl6 also
do not accurately estimate VO2. All these
formulas were developed to offer a suitable
and reliable method to assume VO2 in or-
der to simplify the calculation of hemody-
namic parameters. However, these formu-
las cannot be used in all patients and
settings.
As Benallal pointed out, these formulas
include coefficients depending on charac-
teristics of the population investigated in
these studies. The difference between mea-
sured and assumed VO2 might be due to a
population difference. In addition, it is also
influenced essentially by other conditions
such as the mode of general anesthesia and
relaxation used in different institutions.
It is difficult to identify feasible coeffi-
cients to develop a formula fitting to all con-
ditions of hemodynamic evaluation during
cardiac catheterization.
Moreover, we are convinced that our
population of 143 patients is too small to
identify and validate suitable coefficients
for a new formula. LaFarge and Miettinen
derived their most commonly used formu-
las from a multivariate analysis of covari-
ance applied to data on a series of 879
patients.
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Linking gene expression, nuclear
factor kappa B, remote ischemic
preconditioning, and transplantation:
A quest for an elusive Holy Grail or
a road to an amazing discovery?
To the Editor:
We read with interest the recent paper of
Ishiyama and colleagues1 reporting that in-
hibition of nuclear factor kappa B (NF-B)
by IB supressor gene transfer ameliorated
ischemia-reperfusion (IR) injury after ex-
perimental lung transplantation. A few
comments seem appropriate.
Is activation of NF-B before transplan-
tation destructive or protective? Two mu-
rine studies provided seemingly contradic-
tory results. In the study of Ishiyama and
colleagues,1 inhibition of NF-B rendered
protection against the IR injury, yet in an-
other study2 a targeted deletion of the p105
subunit of the NF-B abolished the protec-
tive effect of the remote ischemic precon-
ditioning (rIPC), a novel clinically applica-
ble mode of protection against IR injury,
whereby the organs can be protected by a
brief ischemia applied remotely (eg, limb
ischemia). Gene expression appears to play
an important role in rIPC. In our own stud-
ies, the rIPC stimulus modified NF-B reg-
ulated gene expression in leukocytes3 and
the target organ,4 and when the rIPC was
applied to the recipient in porcine model it
rendered myocardial protection after the
orthotopic heart transplantation.5
It is widely known that the transcription
factor NF-B can be activated by a variety
of stimuli, for example, tumor necrosis fac-
tor (TNF)-, bacterial lipopolysaccharide
(LPS), and heat shock protein (HSP). Stim-
ulation of the cell may lead to phosphory-
lation of IB and translocation of NF-B
into the nucleus, resulting in gene expres-
sion, including those genes responsible for
exocytosis of adhesive molecules and cy-
tokine production in leukocytes, but also
for production of protective substances eg,
manganese superoxide dismutase (Mn-
SOD) and inducible nitric oxide synthase
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